Citations

Showing 10 of 108152 citations.

Reply
Croome, Kristopher P. , Taner, C. Burcin

Mayo Clinic

Liver Transplantation | September 17, 2019 | Volume: 25 | Issue: 11 | Pages: 1725-1725

10.1002/lt.25640 | PMID 31529605 Get It

Practice guideline update summary: Acute treatment of migraine in children and adolescents
Pringsheim, Tamara , Holler‐Managan, Yolanda, Potrebic, Sonja , Billinghurst, Lori , Gloss, David , Hershey, Andrew D. , Licking, Nicole, Sowell, Michael, Victorio, M. Cristina, Gersz, Elaine , Leininger, Emily, Zanitsch, Heather, Yonker, Marcy, Mack, Kenneth J. , Mack, Kenneth, Hershey, Andrew , Oskoui, Maryam , Pringsheim, Tamara

Mayo Clinic

Headache: The Journal of Head and Face Pain | September 17, 2019 | Volume: 59 | Issue: 8 | Pages: 1158-1173

10.1111/head.13628 | PMID 31529481 Get It

Objective To provide evidence‐based recommendations for the acute symptomatic treatment of children and adolescents with migraine. Methods We performed a systematic review of the literature and rated risk of bias of included studies according to the American Academy of Neurology classification of evidence criteria. A multidisciplinary panel developed practice recommendations, integrating findings from the systematic review and following an Institute of Medicine‐compliant process to ensure transparency and patient engagement. Recommendations were supported by structured rationales, integrating evidence from the systematic review, related evidence, principles of care, and inferences from evidence. Results There is evidence to support the efficacy of the use of ibuprofen, acetaminophen (in children and adolescents), and triptans (mainly in adolescents) for the relief of migraine pain, although confidence in the evidence varies between agents. There is high confidence that adolescents receiving oral sumatriptan/naproxen and zolmitriptan nasal spray are more likely to be headache free at 2 hours than those receiving placebo. No acute treatments were effective for migraine‐related nausea or vomiting; some triptans were effective for migraine‐related phonophobia and photophobia. Recommendations Recommendations for the treatment of acute migraine in children and adolescents focus on the importance of early treatment, choosing the route of administration best suited to the characteristics of the individual migraine attack, and providing counselling on lifestyle factors that can exacerbate migraine, including trigger avoidance and medication overuse.
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention
Pringsheim, Tamara , Billinghurst, Lori , Potrebic, Sonja , Gersz, Elaine , Gloss, David , Holler‐Managan, Yolanda, Leininger, Emily, Licking, Nicole, Mack, Kenneth J. , Powers, Scott W. , Sowell, Michael, Victorio, M. Cristina, Yonker, Marcy, Zanitsch, Heather, Hershey, Andrew D. , Mack, Kenneth, Hershey, Andrew , Oskoui, Maryam

Mayo Clinic

Headache: The Journal of Head and Face Pain | September 17, 2019 | Volume: 59 | Issue: 8 | Pages: 1144-1157

10.1111/head.13625 | PMID 31529477 Get It

Objective To provide updated evidence‐based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population. Methods The authors systematically reviewed literature from January 2003 to August 2017 and developed practice recommendations using the American Academy of Neurology 2011 process, as amended. Results Fifteen class I‐III studies on migraine prevention in children in adolescents met inclusion criteria. There is insufficient evidence to determine if children and adolescents receiving divalproex, onabotulinumtoxinA, amitriptyline, nimodipine and flunarizine are more or less likely than those receiving placebo to have a reduction in headache frequency. Children with migraine receiving propranolol are possibly more likely than those receiving placebo to have an at least 50% reduction in headache frequency. Children and adolescents receiving topiramate and cinnarizine are probably more likely than those receiving placebo to have a decrease in headache frequency. Children with migraine receiving amitriptyline plus cognitive behavioral therapy are more likely than those receiving amitriptyline plus headache education to have a reduction in headache frequency. Recommendations The majority of randomized controlled trials studying the efficacy of preventive medications for pediatric migraine fail to demonstrate superiority to placebo. Recommendations for the prevention of migraine in children include counseling on lifestyle and behavioral factors that influence headache frequency, and assessment and management of comorbid disorders associated with headache persistence. Clinicians should engage in shared decision making with patients and caregivers regarding the use of preventive treatments for migraine, including discussion of the limitations in the evidence to support pharmacologic treatments.
A Multidisciplinary Team-Based Approach to Improve Communication With Surrogates of Patients With Chronic Critical Illness
Greenberg, Jared A. , Gerhart, James , Horst, Jacqueline N., Chen, Elaine , Hunter, Rebecca L. , O’Mahony, Sean , Yeow, Mei-Ean , Fosler, Laura, LaGorio, Lisa A., Meksraityte, Edita, Weiss, Tyler, Geddes, J., Lambe, Stacy S., Fenton, Kara, Hunter, Rebecca L., Nowak, Kristen, Shah, Raj C.

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | September 17, 2019 | Volume: 37 | Issue: 3 | Pages: 214-221

10.1177/1049909119876606 | PMID 31526015 Get It

Background: Clinicians need to deliver prognostic information to surrogates of nondecisional, critically ill patients so that surrogates can make informed medical decisions that reflect the patient’s values. Our objective was to implement a new approach for communicating with surrogates of patients with chronic critical illness. Methods: Surrogate decision makers of patients who were difficult to liberate from mechanical ventilation were prospectively enrolled. Surrogates met with different members of the intensive care unit treatment team for sequential 15-minute appointments to receive patient-specific assessments and education on chronic critical illness. The feasibility and acceptability of this approach were determined. A 24-question comprehension instrument was developed to assess a participant’s understanding that a family member was displaying features of chronic critical illness. Each question was scored from 1 to 5, with larger scores indicating greater comprehension. Results: Over a 15-week period, educational sessions for 9 mechanically ventilated patients were conducted. On average, 2 surrogates per patient (range: 1-4) and 6 members of the interdisciplinary team (range: 4-6) were at each meeting. Surrogates and clinicians had very positive impressions of the communication intervention. The average preintervention comprehension score was 85 of 120 (standard deviation [SD]: 8, range: 71-101). The postintervention comprehension score was greater by 5 points on average (SD: 9, range: −11 to +20 points, P = .04). Conclusions: Surrogates of critically ill patients approved of this novel communication approach and had a greater understanding of the patient’s medical condition after the intervention.
Livin' on the edge
Savica, Rodolfo

Mayo Clinic

Neurology | September 17, 2019 | Volume: 93 | Issue: 15 | Pages: 653-654

10.1212/wnl.0000000000008236 | PMID 31527285 Get It

Mesenchymal Hamartoma in Children: A Diagnostic Challenge
Khan, Muhammad Rehan , Binkovitz, Larry A. , Smyrk, Thomas C. , Potter, D. Dean , Furuya, Katryn N.

Mayo Clinic

Case Reports in Pediatrics | September 16, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-3

10.1155/2019/4132842 | PMID 31637077 Get It

Mesenchymal hamartoma is a benign tumor of the liver with a poorly understood pathogenesis. It is uncommon in older children, especially after 2 years of age. The signs and symptoms may be nonspecific; therefore, a high index of suspicion is required for diagnosis and treatment. We report a 5-year-old previously healthy male who presented with acute abdominal pain, fatigue, and fever. He was diagnosed with pneumonia initially and treated with antibiotics. A computed tomography (CT) scan done for evaluation of his persistent abdominal pain demonstrated a hepatic mass. Follow-up magnetic resonance imaging (MRI) of the liver demonstrated multiple serpiginous tubular-type structures, read as possible Caroli syndrome. He had a normal abdominal examination and normal biochemistries including alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, and alpha-fetoprotein. He was referred to our institution for second opinion. On further review of his imaging studies, the lesion was thought to be a mesenchymal hamartoma. He subsequently underwent resection of the mass. Pathology confirmed the diagnosis of mesenchymal hamartoma.
In high-risk type 1 diabetes, insulin pumps with suspend-before-low technology reduced hypoglycemic events
Kawkgi, Omar El , Montori, Víctor M.

Mayo Clinic

Annals of Internal Medicine | September 16, 2019 | Volume: 171 | Issue: 6 | Pages: JC30

10.7326/acpj201909170-030 | PMID 31525764 Get It

Glycogen storage disease type IV: dilated cardiomyopathy as the isolated initial presentation in an adult patient
Ndugga-Kabuye, Mesaki Kenneth , Maleszewski, Joseph J. , Chanprasert, Sirisak, Smith, Kelly D. , Maleszewski, Joseph

Mayo Clinic

BMJ Case Reports | September 16, 2019 | Volume: 12 | Issue: 9 | Pages: e230068

10.1136/bcr-2019-230068 | PMID 31527204 Get It

Glycogen storage disease type IV (GSD IV, Andersen disease) is a rare autosomal recessive condition. The childhood neuromuscular subtype of GSD IV is characterised by a progressive skeletal myopathy with cardiomyopathy also reported in some individuals. We report a case of a 19-year-old man who presented with severe non-ischaemic dilated cardiomyopathy (NIDCM) necessitating heart transplantation, with biopsy showing aggregations of polyglucosan bodies in cardiac myocytes. He had no signs or symptoms of muscle weakness, liver dysfunction or neurologic involvement. A homozygous GBE1 c.607C>A (p.His203Asn) variant was identified. Our case is unusual in that our patient presented with an isolated NIDCM in the absence of other clinical manifestations of GSD IV. This case highlights the importance of considering storage disorders in young adults presenting with isolated NIDCM of unknown aetiology. It also emphasises the potential synergy between histopathological evaluation and genomic testing in enhancing diagnostic certainty.
Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
Kommoss, Stefan , Tourani, Roshan , Grandelis, Anthony , Uppendahl, Locke , Aliferis, Constantin , Burges, Alexander , Wang, Chen , Canzler, Ulrich , Belau, Antje , Prader, Sonia , Hanker, Lars , Ma, Sisi , Hilpert, Felix , Schneider, Stephanie , Kimmig, Rainer , Kurzeder, Christian , Schmalfeldt, Barbara , Braicu, Elena Ioana , Harter, Philipp , Dowdy, Sean C. , Winterhoff, Boris , Pfisterer, Jacobus , Uppendahl, Locke , Burges, Alexander , Wang, Chen , Heitz, Florian , Ma, Sisi , Ataseven, Beyhan , Sehouli, Jalid , Bois, Andreas du

Mayo Clinic

Clinical Cancer Research | September 16, 2019 | Volume: 26 | Issue: 1 | Pages: 213-219

10.1158/1078-0432.ccr-19-1741 | PMID 31527166 Get It

Abstract Purpose: Predicting surgical outcome could improve individualizing treatment strategies for patients with advanced ovarian cancer. It has been suggested earlier that gene expression signatures (GES) might harbor the potential to predict surgical outcome. Experimental Design: Data derived from high-grade serous tumor tissue of FIGO stage IIIC/IV patients of AGO-OVAR11 trial were used to generate a transcriptome profiling. Previously identified molecular signatures were tested. A theoretical model was implemented to evaluate the impact of medically associated factors for residual disease (RD) on the performance of GES that predicts RD status. Results: A total of 266 patients met inclusion criteria, of those, 39.1% underwent complete resection. Previously reported GES did not predict RD in this cohort. Similarly, The Cancer Genome Atlas molecular subtypes, an independent de novo signature and the total gene expression dataset using all 21,000 genes were not able to predict RD status. Medical reasons for RD were identified as potential limiting factors that impact the ability to use GES to predict RD. In a center with high complete resection rates, a GES which would perfectly predict tumor biological RD would have a performance of only AUC 0.83, due to reasons other than tumor biology. Conclusions: Previously identified GES cannot be generalized. Medically associated factors for RD may be the main obstacle to predict surgical outcome in an all-comer population of patients with advanced ovarian cancer. If biomarkers derived from tumor tissue are used to predict outcome of patients with cancer, selection bias should be focused on to prevent overestimation of the power of such a biomarker. See related commentary by Handley and Sood, p. 9